MacroGenics
MGNX
#9393
Rank
NZ$0.15 B
Marketcap
NZ$2.37
Share price
-0.72%
Change (1 day)
-58.85%
Change (1 year)

Earnings for MacroGenics (MGNX)

Earnings in 2025 (TTM): -NZ$0.13 Billion

According to MacroGenics's latest financial reports the company's current earnings are NZ$0.12 Billion. In 2024 the company made an earning of -NZ$0.12 Billion a decrease over its 2023 earnings that were of -NZ$15.68 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for MacroGenics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.13 Billion12.3%
2024 -NZ$0.12 Billion628.88%
2023 -NZ$15.68 Million-92.44%
2022 -NZ$0.21 Billion-40.75%
2021 -NZ$0.35 Billion55.79%
2020 -NZ$0.23 Billion-14.54%
2019 -NZ$0.27 Billion-11.46%
2018 -NZ$0.3 Billion773.65%
2017 -NZ$33.98 Million-66.47%
2016 -NZ$0.11 Billion190.61%
2015 -NZ$34.87 Million-47.43%
2014 -NZ$66.32 Million14585.78%
2013 -NZ$0.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Xencor
XNCR
-NZ$0.24 Billion 84.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.51 B-15,937.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.96 B-30,953.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$17.11 B-13,310.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.27 B-11,115.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.95 B-30,170.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.90 B-10,834.00%๐Ÿ‡บ๐Ÿ‡ธ USA